Abstract
After myocardial infarction, optimal clinical management depends critically on cardiac imaging. Remodelling and heart failure, presence of inducible ischaemia, presence of dysfunctional viable myocardium, future risk of adverse events including risk of ventricular arrhythmias, need for anticoagulation, and other questions should be addressed by cardiac imaging. Strengths and weaknesses, recent developments, choice, and timing of the different non-invasive techniques are reviewed for this frequent clinical scenario.
MeSH terms
-
Cardiac Volume / physiology
-
Coronary Angiography / methods
-
Diagnostic Imaging / methods*
-
Diastole / physiology
-
Echocardiography / methods
-
Humans
-
Magnetic Resonance Angiography / methods
-
Mitral Valve Insufficiency / diagnosis
-
Mitral Valve Insufficiency / etiology
-
Myocardial Infarction / complications*
-
Myocardial Infarction / pathology
-
Myocardial Infarction / physiopathology
-
Myocardial Ischemia / etiology
-
Myocardial Reperfusion / methods
-
Myocardium / pathology
-
Necrosis / pathology
-
Patient Selection
-
Stress, Physiological / physiology
-
Stroke Volume / physiology
-
Thrombosis / diagnosis
-
Thrombosis / etiology
-
Tomography, X-Ray Computed / methods
-
Ventricular Dysfunction, Left / pathology
-
Ventricular Dysfunction, Left / physiopathology
-
Ventricular Remodeling / physiology